Chrysalium Consulting

To date, nuclear medicine experts have investigated 5 copper isotopes: 60Cu, 61Cu, 62Cu, 64Cu, and 67Cu. Together, these exhibit radiophysical properties that cover both diagnostic and therapeutic applications, encompassing nearly all types of emission—positrons, γ-rays, conversion electrons, and x-rays, as well as β-particles and Auger electrons for therapy—with the exception of α-particles.

PRODUCTION TOOLS WITH LIMITED CAPACITY The relative limited interest from the biopharma industry in 211At-labeled molecules is directly linked to the absence of a reliable, worldwide industrial-scale source of the radionuclide. On the basis of the information provided so far, it is possible to roughly evaluate the yearly production capacity of a single production site and estimate the number of sites needed to cover the main markets.

Thank you for your interest in spreading the word on Journal of Nuclear Medicine. NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Is 211At Really Happening?